NDC 42292-028-01 - Sulfamethoxazole and Trimethoprim
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42292-028
- Requested NDC
- 42292-028-01
- Package NDCs from labels
- 42292-028-01, 42292-028-08
- Manufacturer
- Mylan Institutional Inc.
- Effective date
- 2019-11-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sulfamethoxazole and Trimethoprim Tablets, USP | Mylan Institutional Inc. | 2019-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42292-028-01 | EA - Each | 42292-028 | 82d7d58a-f7df-454e-8242-7401b0345200 | 1 | 2016-12-07 |
| 42292-028-08 | EA - Each | 42292-028 | 82c38478-2a7a-47f8-9fc7-c8b627d74c22 | 1 | 2016-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | A-S Medication Solutions | 0aaf1dbe-b69d-43bd-a4ab-69cb27ab417d | 2025-05-15 | Warnings, Adverse reactions | 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Kesin Pharma | 31f9e720-3869-061f-e063-6294a90a43b4 | 2025-05-13 | Warnings, Adverse reactions | AN164J8Y0X JE42381TNV |
| COLACE EXTRA STRENGTH STOOL SOFTNER | DOCUSATE SODIUM | Atlantis Consumer Healthcare Inc. | 34e06b05-64a5-4b3e-af38-cdcd7c1d521b | 2025-05-01 | Warnings | F05Q2T2JA0 |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Teva Parenteral Medicines, Inc. | bf7a0845-de4f-46be-841a-0faf47f8b530 | 2025-04-30 | Warnings, Adverse reactions | AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | PD-Rx Pharmaceuticals, Inc. | c4da9c4f-0704-4ed5-9d19-5c949f37f726 | 2025-04-30 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Teva Parenteral Medicines, Inc. | b89b5502-ce87-45a6-a43c-9891da3cfca4 | 2025-04-30 | Warnings, Adverse reactions | AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Teva Parenteral Medicines, Inc. | 640f5b0c-748d-4a68-a1de-59cc3e00ed49 | 2025-04-30 | Warnings, Adverse reactions | AN164J8Y0X JE42381TNV |
| Docusate Sodium | DOCUSATE SODIUM | Belleview Bio Science | 335f41d7-5c22-7c17-e063-6294a90a8f28 | 2025-04-22 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | American Health Packaging | e5028f6d-d33d-47a9-8453-00af5cdf59a6 | 2025-04-20 | Warnings | F05Q2T2JA0 |
| Docusate Sodium Oral Liquid | DOCUSATE SODIUM ORAL LIQUID | Kesin Pharma Corporation | 331277b8-8304-d082-e063-6394a90a4dd3 | 2025-04-18 | Warnings | F05Q2T2JA0 |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Sun Pharmaceutical Industries, Inc. | 4833319a-a7b3-4bf4-bec4-6531b43182d4 | 2025-04-03 | Warnings, Adverse reactions | 198334 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Cronus Pharma LLC | 1b5de94f-973a-4b5a-91d7-45e05be78650 | 2025-04-02 | Warnings, Adverse reactions | ANDA090624 198334 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Rising Pharma Holdings, Inc. | e1a3748d-ca73-4e56-95ad-d25189cc346e | 2025-04-02 | Warnings, Adverse reactions | ANDA090624 198334 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | A-S Medication Solutions | 62616708-a538-459f-9b7f-ed90c6aa5fc6 | 2025-04-01 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | A-S Medication Solutions | 14767ff8-7803-4922-ac03-ff80c061e5ba | 2025-03-31 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | A-S Medication Solutions | fd90d8bd-1b84-4347-a98a-f8f94746f3e4 | 2025-03-31 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | A-S Medication Solutions | 4e12b7e1-fa2f-4cd1-ada6-19a7d5652348 | 2025-03-31 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Ailex Pharmaceuticals, LLC | 329655ae-c3c0-46b2-a925-e49777f2076b | 2025-03-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Chartwell RX, LLC | b5b7aba5-f93d-46bc-a3c2-712de1c5cff3 | 2025-03-28 | Warnings, Adverse reactions | AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | PD-Rx Pharmaceuticals, Inc. | 3ef62512-0dc3-4821-9b60-6b375841c4c0 | 2025-03-26 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.